HAVCR2 and neoplasm: Adoptive transfer of CL4 CTL plus both ZM 241385 and anti-TIM3 mAb gave a significant (p < 0.05) reduction in the average final to initial tumor volume ratio compared with mice receiving adoptive CL4 T cell transfer plus ZM 241385 only.